Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acupan
2. Ajan
3. Fenazoxine
4. Hydrochloride, Nefopam
5. Nefopam
6. Nefopam, Silentan
7. Silentan Nefopam
1. 23327-57-3
2. Nefopam Hcl
3. Acupan
4. Fenazoxine Hydrochloride
5. 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-benzo[f][1,4]oxazocine Hydrochloride
6. Nefopam (hydrochloride)
7. Nefopam Hydrochloride [usan]
8. 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-2,5-benzoxazocine Hydrochloride
9. 3,4,5,6-tetrahydro-5-methyl-1-phenyl-1h-2,5-benzoxazocine Hydrochloride
10. 1h-2,5-benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-, Hydrochloride (1:1)
11. 685j48e13w
12. Nsc-757856
13. 23327-57-3 (hcl)
14. 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine;hydrochloride
15. 1h-2,5-benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-, Hydrochloride
16. Dsstox_cid_25441
17. Dsstox_rid_80882
18. Dsstox_gsid_45441
19. Nefopam Hydrochloride (usan)
20. Leoplexamin
21. Pallopikeron
22. Lenipan
23. Sinalgico
24. Oxadol
25. Ajan
26. Smr000514529
27. Sr-01000388442
28. Unii-685j48e13w
29. Prestwick_351
30. Einecs 245-585-5
31. Nefopan Hydrochloride
32. Acupan (tn)
33. 69319-31-9
34. Ncgc00016778-01
35. R 738
36. Cas-23327-57-3
37. Mls001210851
38. Mls001240198
39. Mls002222204
40. Schembl122057
41. Chembl1407915
42. Dtxsid7045441
43. Hms1568n19
44. Nefopam Hydrochloride [mi]
45. Bcp13749
46. Hy-b1057
47. Tox21_110606
48. Mfcd00012750
49. S4180
50. Nefopam Hydrochloride [mart.]
51. 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-benzo[f][1,4]oxazocinehydrochloride
52. Akos015845828
53. Nefopam Hydrochloride [who-dd]
54. Tox21_110606_1
55. Ccg-220229
56. Cs-4579
57. Nsc 757856
58. Nefopam Hydrochloride, >=98% (hplc)
59. Ncgc00094906-06
60. Ac-11999
61. As-13286
62. Cas#23327-57-3
63. Db-046129
64. Ft-0630499
65. N1169
66. C74201
67. D05133
68. Sr-01000388442-1
69. Sr-01000388442-4
70. Q27264216
71. Fenazoxine Hydrochloride; Lenipan; Leoplexamin; Nefopam Hcl
72. Nefopam Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
73. 5-benzoxazocine,5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-hydrochloride
74. 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-benzo[f][1,4]oxazocine Hcl
75. 1h-2,5-benzoxazocine, 5-methyl-1-phenyl-3,4,5,6-tetrahydro-, Hydrochloride
| Molecular Weight | 289.8 g/mol |
|---|---|
| Molecular Formula | C17H20ClNO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 289.1233420 g/mol |
| Monoisotopic Mass | 289.1233420 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 274 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Nefopam Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nefopam Hydrochloride, including repackagers and relabelers. The FDA regulates Nefopam Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nefopam Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nefopam Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nefopam Hydrochloride supplier is an individual or a company that provides Nefopam Hydrochloride active pharmaceutical ingredient (API) or Nefopam Hydrochloride finished formulations upon request. The Nefopam Hydrochloride suppliers may include Nefopam Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Nefopam Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nefopam Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Nefopam Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Nefopam Hydrochloride DMFs exist exist since differing nations have different regulations, such as Nefopam Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nefopam Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Nefopam Hydrochloride USDMF includes data on Nefopam Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nefopam Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nefopam Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nefopam Hydrochloride Drug Master File in Korea (Nefopam Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nefopam Hydrochloride. The MFDS reviews the Nefopam Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Nefopam Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nefopam Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nefopam Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nefopam Hydrochloride suppliers with KDMF on PharmaCompass.
A Nefopam Hydrochloride written confirmation (Nefopam Hydrochloride WC) is an official document issued by a regulatory agency to a Nefopam Hydrochloride manufacturer, verifying that the manufacturing facility of a Nefopam Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nefopam Hydrochloride APIs or Nefopam Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Nefopam Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Nefopam Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Nefopam Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nefopam Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nefopam Hydrochloride GMP manufacturer or Nefopam Hydrochloride GMP API supplier for your needs.
A Nefopam Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Nefopam Hydrochloride's compliance with Nefopam Hydrochloride specifications and serves as a tool for batch-level quality control.
Nefopam Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Nefopam Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nefopam Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Nefopam Hydrochloride EP), Nefopam Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nefopam Hydrochloride USP).
LOOKING FOR A SUPPLIER?
